We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
To support customers as they navigate the path from drug product discovery to commercialization, West has undertaken a new, proactive strategy: Integrated Solutions. For almost 100 years, West has been developing technical and regulatory expertise in primary drug packaging, delivery devices, and combination products. That wealth of industry experience is now offered to customers who can employ it for any stage of development (Prescreen and Compatibility, Clinical Phases I / II / III, and Lifecycle Management).
The need for a strategy such as Integrated Solutions was confirmed by a survey of the over 300 registrants for West’s recent webinar: Navigating Particle Challenges in Sterile Drugs from Component to Patient. Over half of respondents’ report issues with particles resultant from drug/package incompatibility with vials, cartridges or syringes. Further revealed was lack of uniformity on how measurements of particles are made, what conditions are employed, and whether statistical analysis methods are used. Clearly, customers need the support that Integrated Solutions offers.
Particles is a thrust area for West – having the staff, expertise and facilities to design and execute studies needed regarding particle issues – more specifically being able to accurately determine the type, size, concentration and origin of particles in a drug product container system – in particular particles resulting from drug product interactions. The Integrated Solutions strategy helps to Simplify the Journey™ for customers and helps to reduce risk. For more information, contact an Account Manager or Technical Customer Support (TCS) representative.
Simplify the Journey™ is a trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
<p style="margin: 0in 0in 0pt;"><span>Every day, all day, safety matters. Safety never takes a day off. All around us we see safety warnings such as allergens on food labels, use-by-dates on milk and expiration dates on medications. There is no substitute for doing things safely. For pharmaceutical and biotechnology companies offering parenteral drug products, patient safety is the utmost concern.</span></p>
<span>Material characterization is an important part of the selection process of containment/delivery systems for parenteral drug products. </span>
<p>It is essential for companies in the pharmaceutical industry to be prepared to comply with compendial changes as soon as they are enacted. USP Chapter <381> (<em>Elastomeric Closure for Injections</em>), which covers West elastomeric components, is scheduled to be reissued on January 1, 2018 as <em>Components Used in Injectable Pharmaceutical Packaging/Delivery Systems</em></p>
Register today for West’s free educational series <strong>“Supplying Safe Medicines to Patients: Considerations for Container Closure and Delivery Systems”</strong> on March 20, 2014, at the Renaissance Raleigh North Hills Hotel in Raleigh, NC.
Known for a commitment to excellence in elastomeric components, West has complemented its vial closure portfolio with the Flip-Off® seal brand. Particularly in its ability to provide solutions for aseptic and clean crimping, the Flip-Off seal demonstrates potential to become an industry standard.
English
Chinese
